The Foundation for Innovative New Diagnostics (FIND) and Telecom26 AG has announced the launch of a digital connectivity service for the global health community, the company said.
The first-of-its-kind service, named SIMplicity, aims to reduce the burden of sourcing and managing SIM cards for use in connected healthcare devices, including diagnostics equipment, in low resource settings.
SIMplicity is purpose built for global health programmes implementing connectivity, by providing pre-negotiated contracts, low pre-negotiated rates, global coverage with a single SIM, and enhanced management controls.
Although diagnostic instruments enabled with remote connectivity have the potential to increase efficiency and lower costs for testing, treatment and disease surveillance programmes, many healthcare providers in low- and middle-income countries (LMICs) still handwrite test results to record and track disease diagnoses.
Connected diagnostics in LMICs — when available — often rely on locally purchased, pay-as-you-go SIM cards, which can be burdensome, uncontrolled and unsecured. Healthcare programmes using local SIM cards for connectivity may encounter many issues, including deactivation or the inability to re-activate, billing and service-delivery problems, and the absence of quality assurance and reporting mechanisms.
Telecom26 is headquartered in Zug, Switzerland, and is a cross border mobile network operator providing bespoke mobile solutions to global corporations and manufacturers worldwide. Telecom26 utilises a vast global network of over 900 roaming partners, the very latest in SIM technology, and regional roaming solutions.
FIND was established in 2003 as a global non-profit dedicated to accelerating the development, evaluation and delivery of high-quality, affordable diagnostic tests for poverty-related diseases, now including malaria, tuberculosis, HIV/AIDS, sleeping sickness, hepatitis C, leishmaniasis, Chagas disease, Buruli ulcer, non-malarial fever and diseases with outbreak potential, such as Ebola.